Nicholas Donoghoe

Companies

• AbbVieSVP, Enterprise Innovation Jan 4, 2019 to now¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• AbbVie ABBV74,430 shares²$21.1M at $283.40Aug 14, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Aug 14, 2026Sold 32,710 shares at $250.00 of AbbVie²
• Aug 14, 2026Exercised options 32,710 shares at $79.02 of AbbVie²
• Feb 27, 2026Shares withheld for tax 12,874 shares at $232.08 of AbbVie³
• Feb 18, 2026Granted 6,222 shares of AbbVie⁴
• Feb 18, 2026Granted 5,172 shares of AbbVie⁴
• Feb 18, 2026Granted 4,632 shares of AbbVie⁴
• Feb 18, 2026Granted 13,031 shares of AbbVie⁴
• Aug 5, 2025Sold 10,061 shares at $198.59 of AbbVie⁵
• Aug 5, 2025Sold 3,234 shares at $198.27 of AbbVie⁵
• Feb 28, 2025Shares withheld for tax 11,230 shares at $205.02 of AbbVie⁶
• Feb 13, 2025Granted 5,174 shares of AbbVie⁷
• Feb 13, 2025Granted 4,634 shares of AbbVie⁷
• Feb 13, 2025Granted 4,520 shares of AbbVie⁷
• Feb 13, 2025Granted 11,017 shares of AbbVie⁷
• Mar 20, 2024Sold 21,082 shares at $176.30 of AbbVie⁸
• Feb 28, 2024Shares withheld for tax 16,771 shares at $178.99 of AbbVie⁹
• Feb 15, 2024Granted 4,634 shares of AbbVie¹⁰
• Feb 15, 2024Granted 4,520 shares of AbbVie¹⁰
• Feb 15, 2024Granted 6,042 shares of AbbVie¹⁰
• Feb 15, 2024Granted 22,657 shares of AbbVie¹⁰
• Dec 26, 2023Sold 2,912 shares at $154.72 of AbbVie¹¹